Poster Day
Medical Resident-Student Poster Day started in 1997 to encourage resident reporting of clinical cases and elective research. Poster Day is now an annual fall event with other Rochester IM programs and medical students participating. Most years about 25 posters are displayed over 2 sessions for the audience. The event is held before the regional Amercian College of Physicians N.Y. Upstate meeting so that residents can prepare for both meetings.
Prior to Poster Day resident and students can submit abstracts to regional and national ACP competitions. The regional ACP poster session and meeting will be held this year in Syracuse on Oct.24, 2007. Residents and students can submit abstracts by July 29, 2007 for this meeting. Go to the website acponline.org, then the NYS chapter page to find the electronic submission there. The spring 2008, ACP national meeting in Washington DC has separate competitions for residents and students. Individuals can participate by submitting an abstract by Oct. 1, 2007 (residents) or Nov. 1, 2007 (students). Information, instructions and electronic submission is available at: www.acponline.org/srf.
Categories for Poster Day submission are: Research, Clinical Vignette, Patient Safety/Outcome Measurement and Public Policy/Advocacy. Tutorials for abstract and poster preparation will be held for interested residents or students in September. An abstract is not strictly required for Poster Day. Examples of abstracts and posters will be available at the tutorials.
Poster Day (dates, times subject to change)
- Location: Flaum Atrium, Kornberg Research Building, Tuesday Oct. 9, 2007
- Sessions:
- 8-9 AM. General poster viewing and voting by Grand Rounds audience.
- 11:30 AM-1PM. Formal poster competitions by a panel of judges for each section. Residents/students will give 3 minute presentations with a short Q/A period to judges. Poster viewing and voting by audience will continue.
- Prizes: First, second and third place cash awards and inter-departmental recognition will be given to all Poster Day winners. Both the ACP regional and national competitions also offer awards.
Participants in poster day will also have an opportunity to present their work in a special Grand Rounds session called Resident Reviews held each Spring. An example of a scientific abstract from Poster Day 2000 is presented below:
DE NOVO THROMBOTIC MICROANGIOPATHY (TMA) IN RENAL TRANSPLANT RECIPIENTS: A COMPARISON OF HEMOLYTIC UREMIC SYNDROME WITH TMA LOCALIZED TO THE ALLOGRAFT
Joshua Schwimmer, MD (Associate); Tibor Nadasdy, MD; Karen Kaplan, MD; Martin Zand, MD. Department of Medicine, University of Rochester, Rochester, NY.
Background: TMA is a well-recognized and serious complication of renal transplantation. Previous studies of post-transplant TMA have focused on cases of systemic disease resembling hemolytic uremic syndrome (HUS), but rare cases of TMA localized to the renal allograft have also been reported.
Objective: To compare the characteristics of patients with HUS and those with localized TMA.
Methods: 1219 biopsy reports of 742 kidney and kidney-pancreas transplants from 1985 to 2000 were reviewed and 20 cases of TMA identified (2.7%). No patient had a prior history of TMA. Cases were grouped into 1) those with manifestations of HUS (systemic TMA), defined as thrombocytopenia with evidence of significant microangiopathic hemolysis and 2) those with an allograft biopsy diagnosis of TMA without evidence of HUS (localized TMA).
Results: There were 11 cases (55%) of systemic TMA and 9 cases (45%) of localized TMA. Of the 11 patients with systemic TMA, 6 (55%) required dialysis, and 4 (36%) underwent nephrectomy or had TMA-related graft loss. In comparison, no patient with localized TMA required dialysis (0% vs. 55%, p<0.02) or had TMA-related graft loss (0% vs. 36%, p NS). Patients developed systemic TMA earlier than localized TMA (24 +/- 20 d vs. 105 +/- 104 d, p<0.02). Significantly more patients with localized TMA had an end stage renal disease diagnosis of diabetic nephropathy 56% vs. 9%, p<0.05).
Conclusions: Post-transplant TMA was often localized to the kidney with few or no systemic manifestations of HUS. Patients with the systemic form of TMA developed the disease earlier and were significantly more likely to have progressive renal failure requiring dialysis. Patients requiring dialysis had a significantly worse prognosis. This study suggests that localized and systemic TMA have distinct clinical characteristics. Future therapeutic trials should consider distinguishing between the two groups. |
Important Dates (changes will be updated)
Resident/student abstract submission to Upstate ACP competition: July 29, 2007
Resident abstract submission for national competition: Oct. 1, 2007
Student abstract submission for national competition: Nov.1, 2007
see www.acponline.org/srf for further info and forms
ACP Upstate meeting in Syracuse: Wednesday Oct. 24, 2007.
Resident-Student Poster Day at Strong Memorial: Tuesday Oct. 9, 2007.
For further questions and assistance contact: John_Grable@urmc.rochester.edu.
